Incorporation of crizotinib into the NCCN guidelines Journal Article
| Authors: | Riely, G. J.; Chaft, J. E.; Ladanyi, M.; Kris, M. G. |
| Article Title: | Incorporation of crizotinib into the NCCN guidelines |
| Keywords: | immunohistochemistry; treatment response; gene mutation; mutation; histopathology; neutropenia; clinical trials as topic; pyridines; note; lung non small cell cancer; antineoplastic combined chemotherapy protocols; carcinoma, non-small-cell lung; lung neoplasms; epidermal growth factor receptor; protein kinase inhibitors; fluorescence in situ hybridization; gene rearrangement; hybrid protein; societies, medical; pyrazoles; practice guidelines as topic; medical oncology; receptor protein-tyrosine kinases; diagnostic test; tumor gene; molecular diagnostic techniques; crizotinib |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 9 |
| Issue: | 12 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2011-12-01 |
| Start Page: | 1328 |
| End Page: | 1330 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 22157552 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 February 2012" - "Source: Scopus" |
Citation Impact
